Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,784 | 64 | 34.3% |
| Travel and Lodging | $2,730 | 11 | 33.6% |
| Consulting Fee | $1,800 | 1 | 22.2% |
| Unspecified | $804.18 | 7 | 9.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $2,040 | 14 | $0 (2023) |
| AbbVie Inc. | $1,800 | 1 | $0 (2023) |
| Allergan Inc. | $1,631 | 20 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $1,304 | 11 | $0 (2019) |
| Alkermes, Inc. | $351.74 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $220.37 | 3 | $0 (2019) |
| Lundbeck LLC | $217.35 | 14 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $114.36 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $108.92 | 2 | $0 (2021) |
| ITI, Inc. | $102.20 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,959 | 18 | Neurocrine Biosciences, Inc. ($2,040) |
| 2021 | $53.09 | 3 | Lundbeck LLC ($35.77) |
| 2020 | $16.76 | 1 | Lundbeck LLC ($16.76) |
| 2019 | $1,399 | 13 | Avanir Pharmaceuticals, Inc. ($1,304) |
| 2018 | $2,078 | 30 | Allergan Inc. ($1,612) |
| 2017 | $612.23 | 18 | Alkermes, Inc. ($123.48) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/29/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $81.15 | General |
| Category: PSYCHIATRY | ||||||
| 04/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2023 | Stryker Corporation | PREVALON (Device) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: MEDICAL | ||||||
| 02/05/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $65.01 | General |
| 02/05/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | Cash or cash equivalent | $44.58 | General |
| 02/04/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $71.66 | General |
| 02/04/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $49.79 | General |
| 02/04/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $26.06 | General |
| 02/03/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $360.47 | General |
| 02/03/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $140.15 | General |
| 02/03/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $97.94 | General |
| 02/03/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $58.70 | General |
| 02/03/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $49.79 | General |
| 02/02/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $360.47 | General |
| 02/02/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $138.44 | General |
| 02/01/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $387.21 | General |
| 02/01/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $189.75 | General |
| 09/17/2021 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.76 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $80.45 | General |
| 08/06/2019 | Avanir Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $43.53 | General |
| 08/06/2019 | Avanir Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.04 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase IIA US POP w SOD 3125-201-002 | Allergan Inc. | $804.18 | 7 |
About Dr. Bethany Davis, M.D
Dr. Bethany Davis, M.D is a Psychiatry healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881763001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bethany Davis, M.D has received a total of $8,118 in payments from pharmaceutical and medical device companies, with $3,959 received in 2023. These payments were reported across 83 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,784).
Practice Information
- Specialty Psychiatry
- Location Atlanta, GA
- Active Since 11/06/2006
- Last Updated 05/29/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881763001
Products in Payments
- VRAYLAR (Drug) $2,211
- REXULTI (Drug) $161.37
- NUPLAZID (Drug) $114.36
- CAPLYTA (Drug) $102.20
- MYDAYIS (Drug) $51.76
- TRINTELLIX (Drug) $51.17
- Trintellix (Drug) $48.90
- Trulance (Drug) $45.88
- BRINTELLIX (Drug) $22.13
- PREVALON (Device) $16.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Atlanta
Dr. David Purselle, Md, Ms, MD, MS
Psychiatry — Payments: $276,165
Dr. Michael Burke, Md, MD
Psychiatry — Payments: $266,079
Dr. Kerry Ressler, Md,Phd, MD,PHD
Psychiatry — Payments: $180,346
Dr. Alyssa Rosen, M.d, M.D
Psychiatry — Payments: $128,521
Boadie Dunlop, Md, MD
Psychiatry — Payments: $72,811
Patricio Riva Posse, M.d, M.D
Psychiatry — Payments: $66,726